1. Home
  2. RVSB vs TIL Comparison

RVSB vs TIL Comparison

Compare RVSB & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.04

Market Cap

110.8M

Sector

Finance

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.08

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSB
TIL
Founded
1923
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
74.7M
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
RVSB
TIL
Price
$5.04
$7.08
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$7.00
$100.67
AVG Volume (30 Days)
58.2K
182.7K
Earning Date
01-29-2026
11-13-2025
Dividend Yield
1.57%
N/A
EPS Growth
361.12
N/A
EPS
0.22
N/A
Revenue
$52,756,000.00
N/A
Revenue This Year
$10.25
N/A
Revenue Next Year
$11.23
N/A
P/E Ratio
$23.14
N/A
Revenue Growth
15.20
N/A
52 Week Low
$4.74
$5.67
52 Week High
$6.59
$42.79

Technical Indicators

Market Signals
Indicator
RVSB
TIL
Relative Strength Index (RSI) 40.49 30.02
Support Level $4.95 $5.67
Resistance Level $5.16 $12.91
Average True Range (ATR) 0.13 0.75
MACD -0.02 -0.23
Stochastic Oscillator 22.39 19.75

Price Performance

Historical Comparison
RVSB
TIL

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: